Synergistic attenuation of ovariectomy-induced bone loss by combined use of fish oil and 17β-oestradiol

Youri Jin, Myoungsook Lee, Yongsoon Park

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Oestrogen and n-3 PUFA, especially EPA and DHA, have been reported to have beneficial effects on bone loss. Thus, the purpose of the present study was to investigate the synergistic bone-protective mechanism of combined treatments of EPA+DHA supplementation and oestrogen injection in ovariectomised rats. Rats were fed a modified American Institute of Nutrition-93G diet with 0 %, 1 % or 2 % n-3 PUFA (EPA+DHA) relative to the total energy intake for 12 weeks. Rats were surgically ovariectomised at week 8, and after a 1-week recovery period rats were injected with either 17β-oestradiol-3-benzoate (E2) or maize oil for the last 3 weeks. Combined use of n-3 PUFA and E2 synergistically increased femoral cortical bone volume, bone mineral content and the bone expression of runt-related transcription factor 2 (RUNX2), but decreased the bone expression of IL-1β. Both n-3 PUFA and E2 decreased the bone expressions of IL-7, TNF-α and PPAR-γ, and increased the bone expression of oestrogen receptor-α. n-3 PUFA in the presence of E2 and E2 alone significantly decreased the bone expressions of IL-1β and IL-6 and increased the bone expression of RUNX2. E2 significantly decreased the serum levels of bone turnover markers and the bone expression of receptor activator of NF-κB ligand, but decreased the bone expression of osteoprotegerin. The combined use of n-3 PUFA and E2 exerted synergistic bone-protective efficacy through up-regulation of RUNX2, an essential transcription factor for bone formation, as well as the suppression of bone-resorbing cytokine IL-1β.

Original languageEnglish
Pages (from-to)479-489
Number of pages11
JournalBritish Journal of Nutrition
Volume117
Issue number4
DOIs
StatePublished - 2017 Feb 28

Fingerprint

Fish Oils
Ovariectomy
Estradiol
Bone and Bones
Omega-3 Fatty Acids
Interleukin-1
Estrogens
Transcription Factors
Osteoprotegerin
Interleukin-7
Peroxisome Proliferator-Activated Receptors
Corn Oil
Bone Remodeling
Thigh
Energy Intake
Osteogenesis
Estrogen Receptors
Bone Density
Interleukin-6
Up-Regulation

Keywords

  • 17β-oestradiol-3-benzoate
  • Bone loss
  • IL-1ß
  • Runt-related transcription factor 2
  • n-3 PUFA

Cite this

@article{82106b5a96884a1e8d84efe47aa7795b,
title = "Synergistic attenuation of ovariectomy-induced bone loss by combined use of fish oil and 17β-oestradiol",
abstract = "Oestrogen and n-3 PUFA, especially EPA and DHA, have been reported to have beneficial effects on bone loss. Thus, the purpose of the present study was to investigate the synergistic bone-protective mechanism of combined treatments of EPA+DHA supplementation and oestrogen injection in ovariectomised rats. Rats were fed a modified American Institute of Nutrition-93G diet with 0 {\%}, 1 {\%} or 2 {\%} n-3 PUFA (EPA+DHA) relative to the total energy intake for 12 weeks. Rats were surgically ovariectomised at week 8, and after a 1-week recovery period rats were injected with either 17β-oestradiol-3-benzoate (E2) or maize oil for the last 3 weeks. Combined use of n-3 PUFA and E2 synergistically increased femoral cortical bone volume, bone mineral content and the bone expression of runt-related transcription factor 2 (RUNX2), but decreased the bone expression of IL-1β. Both n-3 PUFA and E2 decreased the bone expressions of IL-7, TNF-α and PPAR-γ, and increased the bone expression of oestrogen receptor-α. n-3 PUFA in the presence of E2 and E2 alone significantly decreased the bone expressions of IL-1β and IL-6 and increased the bone expression of RUNX2. E2 significantly decreased the serum levels of bone turnover markers and the bone expression of receptor activator of NF-κB ligand, but decreased the bone expression of osteoprotegerin. The combined use of n-3 PUFA and E2 exerted synergistic bone-protective efficacy through up-regulation of RUNX2, an essential transcription factor for bone formation, as well as the suppression of bone-resorbing cytokine IL-1β.",
keywords = "17β-oestradiol-3-benzoate, Bone loss, IL-1{\ss}, Runt-related transcription factor 2, n-3 PUFA",
author = "Youri Jin and Myoungsook Lee and Yongsoon Park",
year = "2017",
month = "2",
day = "28",
doi = "10.1017/S0007114517000344",
language = "English",
volume = "117",
pages = "479--489",
journal = "British Journal of Nutrition",
issn = "0007-1145",
number = "4",

}

Synergistic attenuation of ovariectomy-induced bone loss by combined use of fish oil and 17β-oestradiol. / Jin, Youri; Lee, Myoungsook; Park, Yongsoon.

In: British Journal of Nutrition, Vol. 117, No. 4, 28.02.2017, p. 479-489.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Synergistic attenuation of ovariectomy-induced bone loss by combined use of fish oil and 17β-oestradiol

AU - Jin, Youri

AU - Lee, Myoungsook

AU - Park, Yongsoon

PY - 2017/2/28

Y1 - 2017/2/28

N2 - Oestrogen and n-3 PUFA, especially EPA and DHA, have been reported to have beneficial effects on bone loss. Thus, the purpose of the present study was to investigate the synergistic bone-protective mechanism of combined treatments of EPA+DHA supplementation and oestrogen injection in ovariectomised rats. Rats were fed a modified American Institute of Nutrition-93G diet with 0 %, 1 % or 2 % n-3 PUFA (EPA+DHA) relative to the total energy intake for 12 weeks. Rats were surgically ovariectomised at week 8, and after a 1-week recovery period rats were injected with either 17β-oestradiol-3-benzoate (E2) or maize oil for the last 3 weeks. Combined use of n-3 PUFA and E2 synergistically increased femoral cortical bone volume, bone mineral content and the bone expression of runt-related transcription factor 2 (RUNX2), but decreased the bone expression of IL-1β. Both n-3 PUFA and E2 decreased the bone expressions of IL-7, TNF-α and PPAR-γ, and increased the bone expression of oestrogen receptor-α. n-3 PUFA in the presence of E2 and E2 alone significantly decreased the bone expressions of IL-1β and IL-6 and increased the bone expression of RUNX2. E2 significantly decreased the serum levels of bone turnover markers and the bone expression of receptor activator of NF-κB ligand, but decreased the bone expression of osteoprotegerin. The combined use of n-3 PUFA and E2 exerted synergistic bone-protective efficacy through up-regulation of RUNX2, an essential transcription factor for bone formation, as well as the suppression of bone-resorbing cytokine IL-1β.

AB - Oestrogen and n-3 PUFA, especially EPA and DHA, have been reported to have beneficial effects on bone loss. Thus, the purpose of the present study was to investigate the synergistic bone-protective mechanism of combined treatments of EPA+DHA supplementation and oestrogen injection in ovariectomised rats. Rats were fed a modified American Institute of Nutrition-93G diet with 0 %, 1 % or 2 % n-3 PUFA (EPA+DHA) relative to the total energy intake for 12 weeks. Rats were surgically ovariectomised at week 8, and after a 1-week recovery period rats were injected with either 17β-oestradiol-3-benzoate (E2) or maize oil for the last 3 weeks. Combined use of n-3 PUFA and E2 synergistically increased femoral cortical bone volume, bone mineral content and the bone expression of runt-related transcription factor 2 (RUNX2), but decreased the bone expression of IL-1β. Both n-3 PUFA and E2 decreased the bone expressions of IL-7, TNF-α and PPAR-γ, and increased the bone expression of oestrogen receptor-α. n-3 PUFA in the presence of E2 and E2 alone significantly decreased the bone expressions of IL-1β and IL-6 and increased the bone expression of RUNX2. E2 significantly decreased the serum levels of bone turnover markers and the bone expression of receptor activator of NF-κB ligand, but decreased the bone expression of osteoprotegerin. The combined use of n-3 PUFA and E2 exerted synergistic bone-protective efficacy through up-regulation of RUNX2, an essential transcription factor for bone formation, as well as the suppression of bone-resorbing cytokine IL-1β.

KW - 17β-oestradiol-3-benzoate

KW - Bone loss

KW - IL-1ß

KW - Runt-related transcription factor 2

KW - n-3 PUFA

UR - http://www.scopus.com/inward/record.url?scp=85015211746&partnerID=8YFLogxK

U2 - 10.1017/S0007114517000344

DO - 10.1017/S0007114517000344

M3 - Article

C2 - 28290259

AN - SCOPUS:85015211746

VL - 117

SP - 479

EP - 489

JO - British Journal of Nutrition

JF - British Journal of Nutrition

SN - 0007-1145

IS - 4

ER -